India's drug regulator has approved Itolizumab, used to cure skin ailment psoriasis, for restricted emergency use on COVID-19 patients with moderate to severe acute respiratory distress, officials......
Rise in raids on illicit drug manufacturing units, alongside arrests for the production, sale, or distribution of spurious or adulterated drugs. Photograph: Yves Herman/Reuters The......
A probe has been initiated by India's drug regulator after the World Health Organisation (WHO) issued an alert saying cough syrups manufactured by an Indian firm could potentially be linked to the......
Vaccine makers in India have a limited stockpile of doses, even as COVID-19 threatens to rear its head this winter season, reports Sohini Das. IMAGE: A beneficiary is being inoculated with a......
A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on......
As the Drugs Controller General of India (DCGI) is set to crack down on companies to ensure compliance with printing QR codes on top-selling brands to curb counterfeiting, top pharma companies say......
At a time India-made medicines appear to be losing sheen the world over, the country’s top regulator, the Drug Controller General of India (DCGI), is struggling to ensure quality of drugs in......
With an eye on improving quality assurance in the wake of increased global scrutiny on Indian pharma products, the Centre on Tuesday said that Schedule M of the Drugs and Cosmetics Act, 1940 will......
Avigan comes in a complete therapy pack of 122 tablets with a two-year shelf life. Dr Reddy's Laboratories on Wednesday announced the launch of Avigan (favipiravir) 200 mg tablets in India. The......
Favipiravir is the only oral anti-viral treatment approved in India for potential treatment of patients with mild to moderate Covid-19 disease. Joining the long list of firms to launch its own......